Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00842868 · ClinicalTrials.gov registry record
The CASABLANCA Study: Catheter Sampled Blood Archive in Cardiovascular Diseases
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 1,298
- Enrollment target
NCT00842868: Completed study, sponsored by Massachusetts General Hospital.
NCT00842868 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 1,298 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00842868 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 1,298 participants
- Enrollment target
Study Summary
The purpose of this research is to determine the relationship between novel blood tests for heart function (including hormones and heart enzymes measured in the blood), and assess for kidney damage before and after angiography (cardiac catheterization). We hypothesize that these novel tests will enable us to predict possible complications of catheterization immediately after the procedure.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,298 participants |
| Start Date | 2008-09 |
| Est. Completion | 2015-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00842868
The ClinicalTrials.gov registry entry for NCT00842868 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,298 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00842868 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00842868 about?
NCT00842868 is a clinical study titled "The CASABLANCA Study: Catheter Sampled Blood Archive in Cardiovascular Diseases". The purpose of this research is to determine the relationship between novel blood tests for heart function (including hormones and heart enzymes measured in the blood), and assess for kidney damage before and after angiography (cardiac catheterization). We hypothesize that these novel tests will ena...
What is the current status of trial NCT00842868?
This trial is currently completed. The enrollment target is 1,298 participants. The study started on 2008-09. Estimated completion is 2015-03.
Who is sponsoring clinical trial NCT00842868?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.